Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.

Successful human vaccination by synthetic malarial sporozoite peptides may depend on the choice of an appropriate carrier. Tetanus toxoid (TT) has been proposed because of its safe and widespread use in humans. Paradoxically, however, prior exposure to this toxoid vaccine could produce specific epit...

Celý popis

Podrobná bibliografie

Vydáno v:	Infect Immun
Hlavní autoři:	Lise, L D, Mazier, D, Jolivet, M, Audibert, F, Chedid, L, Schlesinger, D
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1987
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC259957/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2444539/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.55.11.2658-2661.1987
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!